Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

  1. Marcianes, P.
  2. Negro, S.
  3. Barcia, E.
  4. Montejo, C.
  5. Fernández-Carballido, A.
Zeitschrift:
AAPS PharmSciTech

ISSN: 1530-9932

Datum der Publikation: 2020

Ausgabe: 21

Nummer: 1

Art: Artikel

DOI: 10.1208/S12249-019-1552-3 GOOGLE SCHOLAR